A listing of Peginterferon Alfa-2A medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Background Chronic hepatitis B virus (HBV) infection affects 292 million people worldwide; 887,000 die each year from cirrhosis, liver cancer, and related issues. Treatment options are limited. Objective To test 2 drugs (VIR-2218 and peginterferon) in people with mild or inactive HBV infection. Eligibility People aged 18 to 65 years …
Congrats! You have your own personal workspace now.